fluoxetine has been researched along with gamma-aminobutyric acid in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (5.00) | 18.7374 |
1990's | 10 (16.67) | 18.2507 |
2000's | 23 (38.33) | 29.6817 |
2010's | 21 (35.00) | 24.3611 |
2020's | 3 (5.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
Anderson, GM; Craig, JS; During, MJ; Gallager, DW; Hernandez, TD | 1 |
Iovino, M; Maj, M; Monteleone, P; Steardo, L | 1 |
Colmers, WF; Pan, ZZ; Williams, JT | 1 |
Lloyd, KG; Pilc, A; Thuret, F | 1 |
Aghajanian, GK; De Montigny, C; Reader, TA; Wang, RY | 1 |
Goodwin, WB; Guyenet, PG; Huangfu, D | 1 |
Gale, K; Pasini, A; Tortorella, A | 1 |
Cooper, TB; Costa, E; Guidotti, A; Uzunov, DP | 1 |
Corá-Locatelli, G; Greenberg, BD; Martin, JD; Murphy, DL | 1 |
Matthews, J; Pollack, MH; Scott, EL | 1 |
Corá-Locatelli, G; Greenberg, BD; Martin, J; Murphy, DL | 1 |
Crites, GJ; Goldenberg, R; Malatynska, E; Schindler, NL; Tunnicliff, G; Yochum, A | 1 |
Churchill, LE; Connor, KM; Davidson, JR; Foa, EB | 1 |
Drafts, BC; Fisher, JL; Robinson, RT | 1 |
Bernardi, G; di Michele, F; Pace, M; Pasinib, A; Pompili, E; Romeo, E; Rupprecht, R | 1 |
Christodoulou, GN; Dimopoulos, NP; Gitsa, OE; Liappas, AI; Liappas, IA; Malitas, PN; Nikolaou, CK | 1 |
Chan, W; Yen, HL | 1 |
Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY | 1 |
Chopde, CT; Hirani, K; Mittal, N; Ugale, RR | 1 |
Yan, Z; Zhong, P | 1 |
Forray, MI; Gysling, K; Sotomayor, R | 1 |
Akaike, A; Katsuki, H | 1 |
Blackburn-Munro, G; Nielsen, AN; Pedersen, LH | 1 |
Anglard, P; Aunis, D; Burgun, C; Carouge, D; Cassel, S; Dietrich, JB; Gensburger, C; Zwiller, J | 1 |
Fonteles, MM; Freitas, RM; Sousa, FC; Viana, GS | 1 |
Davies, M; Derry, JM; Dunn, SM; Paulsen, IM | 1 |
Alexander, IM; Moore, A | 1 |
Berkman, K; Gören, MZ; Küçükibrahimoglu, E; Terzioglu, B | 1 |
Gökbakan, M; Onder, E; Tural, U | 1 |
Baroncelli, L; Castrén, E; De Pasquale, R; Maffei, L; Maya Vetencourt, JF; O'Leary, OF; Sale, A; Viegi, A | 1 |
Xu, TL; Ye, ZY; Zhou, JN; Zhou, KQ | 1 |
Costa, E; Guidotti, A; Pinna, G | 1 |
Calişkan, M; Gören, MZ; Kaplan, OK; Küçükibrahimoğlu, E; Saygin, MZ; Unsal, C | 1 |
Aharoni, A; Geffen, Y; Gil-Ad, I; Halbfinger, E; Nisemblat, Y; Nudelman, A; Rephaeli, A; Tarasenko, I; Tarasenko, N; Weizman, A | 1 |
Egeland, M; Greengard, P; Svenningsson, P; Warner-Schmidt, J | 1 |
Choi, HC; Kang, TC; Kim, DS; Kim, JE; Kim, YI; Song, HK | 1 |
Dempsey, CM; Griffin, CT; Hapiak, VM; Komuniecki, RW; Kuan, CJ; Kullyev, A; Miller, S; Sze, JY | 1 |
MacGregor, EA | 1 |
Bain, MJ; Fan, CM | 1 |
Girbig, D; Igl, BW; Lehmann, T; Obendorf, M; Patchev, VK; Prelle, K | 1 |
Abdel-Daiem, WM; Abdel-Sater, KA; Sayyed Bakheet, M | 1 |
Bacci, A; Méndez, P; Pazienti, A; Szabó, G | 1 |
Iwanaga, T; Miyakawa, T; Ohira, K; Takeuchi, R | 1 |
Baroncelli, L; Begenisic, T; Bonanno, G; Bonifacino, T; Cioni, G; Maffei, L; Milanese, M; Sale, A; Sansevero, G | 1 |
Gao, X; Qiao, M; Sun, P; Wei, S; Xue, L; Zhang, H | 1 |
Pehrson, AL; Sanchez, C | 1 |
Denenberg, S | 1 |
Oflaz, S; Soyata, AZ | 1 |
Ghorbani, R; Mohseni, A; Rahmanian, M | 1 |
André, E; de Sousa Pinto, ÍA; Gavioli, EC; Lovick, T; Santos, RO; Soares-Rachetti, Vde P | 1 |
DuBois, DW; Fincher, AS; Frye, GD; Henry, MM; Morgan, C; Shannonhouse, JL; Vela, AM; Wellman, PJ | 1 |
Nudmamud-Thanoi, S; Roboon, J; Thanoi, S | 1 |
Chung, SK; Lam, LC; Ma, SL; So, KF; Tsim, KW; Wong, YH; Yeung, PK; Zhou, L | 1 |
Flais, I; Lazarevic, V; Mantas, I; Svenningsson, P | 1 |
Di, T; Guo, J; Guo, X; Li, P; Liu, Y; Meng, Y; Qi, C; Wang, Y; Zhang, L; Zhao, J | 1 |
Chen, S; Chen, Z; Feng, P; Gu, J; Lin, S; Tao, Y; Wang, P; Xu, H; Xu, Z; Zhao, J | 1 |
Chi, X; Lu, Y; Ma, K; Pan, J; Shi, H; Wang, Y; Wu, J; Xue, X; Zhang, Z | 1 |
5 review(s) available for fluoxetine and gamma-aminobutyric acid
Article | Year |
---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
Treating vasomotor symptoms of menopause: the nurse practitioner's perspective.
Topics: Adrenergic alpha-Agonists; Algorithms; Amines; Citalopram; Clonidine; Complementary Therapies; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Life Style; Menopause; Middle Aged; Nurse Practitioners; Paroxetine; Patient Education as Topic; Patient Selection; Practice Guidelines as Topic; Primary Health Care; Safety Management; Selective Serotonin Reuptake Inhibitors | 2007 |
SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake.
Topics: Animals; Brain; Fluoxetine; gamma-Aminobutyric Acid; Humans; Mental Disorders; Mood Disorders; Pregnanolone; Receptors, GABA-A; Selective Serotonin Reuptake Inhibitors; Social Isolation; Synaptic Transmission | 2009 |
Perimenopausal migraine in women with vasomotor symptoms.
Topics: Amines; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Estrogens; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Migraine Disorders; Neurotransmitter Agents; Perimenopause | 2012 |
Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants.
Topics: Animals; Antidepressive Agents; Brain; Depressive Disorder, Major; Evidence-Based Medicine; Fluoxetine; GABA Agents; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Neural Inhibition; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Sulfides; Synaptic Transmission; Vortioxetine | 2015 |
4 trial(s) available for fluoxetine and gamma-aminobutyric acid
Article | Year |
---|---|
Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder.
Topics: Acetates; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Obsessive-Compulsive Disorder; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1998 |
Effects of fluoxetine, indomethacine and placebo on 3 alpha, 5 alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal.
Topics: Adult; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Ethanol; Fluoxetine; gamma-Aminobutyric Acid; Humans; Indomethacin; Male; Pregnanolone; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2000 |
Does gabapentin lead to early symptom improvement in obsessive-compulsive disorder?
Topics: Administration, Oral; Adolescent; Adult; Amines; Analysis of Variance; Anti-Anxiety Agents; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2008 |
A crossover study comparing gabapentin and fluoxetine for the treatment of vasomotor symptoms among postmenopausal women.
Topics: Amines; Cross-Over Studies; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Iran; Middle Aged; Postmenopause; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Sweating; Treatment Outcome | 2015 |
51 other study(ies) available for fluoxetine and gamma-aminobutyric acid
Article | Year |
---|---|
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Effect of amygdala kindling on the in vivo release of GABA and 5-HT in the dorsal raphe nucleus in freely moving rats.
Topics: Amino Acids; Amygdala; Animals; Dialysis; Fluoxetine; gamma-Aminobutyric Acid; Kindling, Neurologic; Male; Nipecotic Acids; Potassium; Proline; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin; Tetrodotoxin; Veratridine | 1992 |
GABA, depression and the mechanism of action of antidepressant drugs: a neuroendocrine approach.
Topics: Adult; Amitriptyline; Antidepressive Agents; Baclofen; Brain; Depressive Disorder; Fluoxetine; gamma-Aminobutyric Acid; Growth Hormone; Humans; Imipramine; Male; Middle Aged; Personality Tests; Receptors, GABA-A | 1990 |
5-HT-mediated synaptic potentials in the dorsal raphe nucleus: interactions with excitatory amino acid and GABA neurotransmission.
Topics: Animals; Electric Stimulation; Fluoxetine; gamma-Aminobutyric Acid; In Vitro Techniques; Membrane Potentials; Neurons; Pons; Raphe Nuclei; Rats; Serotonin; Spiperone; Synapses | 1989 |
Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock.
Topics: Animals; Antidepressive Agents; Cerebral Cortex; Desipramine; Dose-Response Relationship, Drug; Electroshock; Fluoxetine; gamma-Aminobutyric Acid; Hippocampus; Kinetics; Male; Monoamine Oxidase Inhibitors; Nomifensine; Rats; Rats, Inbred Strains; Receptors, GABA-A; Serotonin Antagonists; Time Factors; Viloxazine | 1985 |
Monoaminergic denervation of the rat hippocampus: microiontophoretic studies on pre- and postsynaptic supersensitivity to norepinephrine and serotonin.
Topics: Animals; Denervation; Desipramine; Dihydroxytryptamines; Fluoxetine; gamma-Aminobutyric Acid; Hippocampus; Hydroxydopamines; Isoproterenol; Locus Coeruleus; Male; Norepinephrine; Rats; Serotonin; Synapses | 1980 |
Sympatholytic effect of tricyclic antidepressants: site and mechanism of action in anesthetized rats.
Topics: Adrenergic alpha-Antagonists; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Baclofen; Blood Pressure; Brain Mapping; Desipramine; Dioxanes; Fluoxetine; gamma-Aminobutyric Acid; Idazoxan; Imidazoles; Male; Medulla Oblongata; Microinjections; Nordefrin; Oxidopamine; Rats; Rats, Sprague-Dawley; Splanchnic Nerves; Sympatholytics; Time Factors | 1995 |
The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anticonvulsants; Bicuculline; Convulsants; Fenclonine; Fluoxetine; gamma-Aminobutyric Acid; Male; Microinjections; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Substantia Nigra | 1996 |
Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography.
Topics: 20-alpha-Dihydroprogesterone; Adrenalectomy; Animals; Brain; Castration; Fluoxetine; GABA Modulators; gamma-Aminobutyric Acid; Gas Chromatography-Mass Spectrometry; Imipramine; Male; Paroxetine; Pregnanolone; Progesterone; Rats; Rats, Sprague-Dawley | 1996 |
Rebound psychiatric and physical symptoms after gabapentin discontinuation.
Topics: Acetates; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Obsessive-Compulsive Disorder; Recurrence; Substance Withdrawal Syndrome | 1998 |
Gabapentin as a potential treatment for anxiety disorders.
Topics: Acetates; Adult; Alprazolam; Amines; Anticonvulsants; Anxiety Disorders; Cyclohexanecarboxylic Acids; Diazepam; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Panic Disorder; Phobic Disorders | 1998 |
The GABA(A) receptor complex as a target for fluoxetine action.
Topics: Animals; Chlorides; Dose-Response Relationship, Drug; Flunitrazepam; Fluoxetine; gamma-Aminobutyric Acid; Ion Transport; Male; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Selective Serotonin Reuptake Inhibitors; Tritium | 1999 |
Treating hot flashes with drugs: an update.
Topics: Acetates; Amines; Anticonvulsants; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Venlafaxine Hydrochloride | 2002 |
Hyperhidrosis in social anxiety disorder.
Topics: Acetates; Adult; Amines; Calcium Channel Blockers; Clinical Trials as Topic; Clonazepam; Cognitive Behavioral Therapy; Cyclohexanecarboxylic Acids; Female; Fluoxetine; GABA Modulators; Gabapentin; gamma-Aminobutyric Acid; Humans; Hyperhidrosis; Male; Phobic Disorders; Prognosis; Retrospective Studies; Selective Serotonin Reuptake Inhibitors | 2002 |
Fluoxetine increases GABA(A) receptor activity through a novel modulatory site.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; gamma-Aminobutyric Acid; Mammals; Receptors, GABA-A; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors | 2003 |
Three cases of zolpidem dependence treated with fluoxetine: the serotonin hypothesis.
Topics: Adult; Female; Fluoxetine; GABA Agonists; gamma-Aminobutyric Acid; Humans; Male; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin; Substance-Related Disorders; Treatment Outcome; Zolpidem | 2003 |
An East-West approach to the management of central post-stroke pain.
Topics: Acetates; Acupuncture; Aged; Amines; Amitriptyline; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Male; Pain; Pain Management; Physical Therapy Modalities; Stroke; Tramadol; Triazines | 2003 |
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; gamma-Aminobutyric Acid; Male; Mice; Pentylenetetrazole; Pregnanolone; Seizures | 2004 |
Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons.
Topics: Animals; Antidepressive Agents; Evoked Potentials; Fluoxetine; gamma-Aminobutyric Acid; Organ Culture Techniques; Patch-Clamp Techniques; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Time Factors | 2004 |
Acute morphine administration increases extracellular DA levels in the rat lateral septum by decreasing the GABAergic inhibitory tone in the ventral tegmental area.
Topics: Analysis of Variance; Animals; Dopamine; Drug Administration Schedule; Extracellular Fluid; Fluoxetine; gamma-Aminobutyric Acid; Male; Microdialysis; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neural Pathways; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Septum of Brain; Serotonin; Statistics, Nonparametric; Ventral Tegmental Area | 2005 |
Quinolinic acid toxicity on orexin neurons blocked by gamma aminobutyric acid type A receptor stimulation.
Topics: Animals; Animals, Newborn; Bicuculline; Cell Count; Citalopram; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Hypothalamus; Immunohistochemistry; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Magnesium; Neurons; Neuropeptides; Nipecotic Acids; Norepinephrine; Orexin Receptors; Orexins; Organophosphorus Compounds; Picrotoxin; Quinolinic Acid; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, GABA-A; Receptors, Neuropeptide; Selective Serotonin Reuptake Inhibitors; Serotonin | 2005 |
Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain.
Topics: Amines; Analgesics; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Constriction; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Male; Morpholines; Motor Activity; Neurotransmitter Uptake Inhibitors; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Reboxetine; Rotarod Performance Test; Spinal Cord Injuries; Vesicular Monoamine Transport Proteins | 2005 |
Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain.
Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Cocaine; DNA-Binding Proteins; Epigenesis, Genetic; Fluoxetine; gamma-Aminobutyric Acid; Immunohistochemistry; Male; Methyl-CpG-Binding Protein 2; Rats; Rats, Wistar; RNA, Messenger; Serotonin | 2006 |
Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus.
Topics: Amines; Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Ketamine; Male; Muscarinic Agonists; N-Methylaspartate; Pilocarpine; Pimozide; Rats; Seizures; Status Epilepticus | 2006 |
A single point mutation of the GABA(A) receptor alpha5-subunit confers fluoxetine sensitivity.
Topics: Amino Acid Substitution; Animals; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Fluoxetine; GABA Agonists; gamma-Aminobutyric Acid; Isoxazoles; Membrane Potentials; Models, Molecular; Mutagenesis; Mutation; Oocytes; Patch-Clamp Techniques; Protein Subunits; Receptors, GABA-A; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Xenopus laevis | 2007 |
Fluoxetine partly exerts its actions through GABA: a neurochemical evidence.
Topics: Animals; Fluoxetine; gamma-Aminobutyric Acid; Glutamic Acid; Male; Rats; Rats, Sprague-Dawley | 2007 |
The antidepressant fluoxetine restores plasticity in the adult visual cortex.
Topics: Amblyopia; Animals; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Diazepam; Dominance, Ocular; Evoked Potentials, Visual; Fluoxetine; gamma-Aminobutyric Acid; Long-Term Potentiation; Long-Term Synaptic Depression; Neuronal Plasticity; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Visual Cortex | 2008 |
Fluoxetine potentiates GABAergic IPSCs in rat hippocampal neurons.
Topics: Animals; Cells, Cultured; Fluoxetine; gamma-Aminobutyric Acid; Hippocampus; Inhibitory Postsynaptic Potentials; Neurons; Patch-Clamp Techniques; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission | 2008 |
The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression.
Topics: Antidepressive Agents, Second-Generation; Case-Control Studies; Chromatography, High Pressure Liquid; Citalopram; Depression; Female; Fluoxetine; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans | 2009 |
Gamma-aminobutyric acid amides of nortriptyline and fluoxetine display improved pain suppressing activity.
Topics: Analgesics; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Fluoxetine; Formaldehyde; gamma-Aminobutyric Acid; Inflammation; Male; Mice; Nortriptyline; Pain; Rats | 2009 |
Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice.
Topics: Analysis of Variance; Animals; Annexin A2; Behavior, Animal; Cell Proliferation; Cell Survival; Fluoxetine; gamma-Aminobutyric Acid; Hippocampus; Immunohistochemistry; In Situ Hybridization; Male; Mice; Mice, Knockout; Microscopy, Fluorescence; Neurogenesis; Neuronal Plasticity; Neurons; S100 Proteins; Selective Serotonin Reuptake Inhibitors | 2010 |
Effects of selective serotonin reuptake inhibitors on GABAergic inhibition in the hippocampus of normal and pilocarpine induced epileptic rats.
Topics: Analysis of Variance; Animals; Citalopram; Electroencephalography; Epilepsy; Fluoxetine; gamma-Aminobutyric Acid; Hippocampus; Male; Neural Inhibition; Neurons; Paroxetine; Pilocarpine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vesicular Inhibitory Amino Acid Transport Proteins | 2010 |
A genetic survey of fluoxetine action on synaptic transmission in Caenorhabditis elegans.
Topics: Acetylcholine; Animals; Behavior, Animal; Biological Assay; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Fluoxetine; gamma-Aminobutyric Acid; Glutamic Acid; Muscle Relaxation; Mutation; Neurons; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Signal Transduction; Synaptic Transmission | 2010 |
Animal behavior case of the month. Motivation for the tail-chasing behavior was considered to most likely be multifactorial.
Topics: Acepromazine; Amines; Animals; Anticonvulsants; Behavior, Animal; Compulsive Behavior; Cyclohexanecarboxylic Acids; Displacement, Psychological; Dog Diseases; Dogs; Dopamine Antagonists; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Selective Serotonin Reuptake Inhibitors | 2012 |
Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease.
Topics: Acetamides; Amines; Animals; Body Temperature Regulation; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Diurnal Enuresis; Drug Discovery; Estradiol; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Hypnotics and Sedatives; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Skin Temperature; Venlafaxine Hydrochloride | 2012 |
The gender difference of selective serotonin reuptake inhibitor, fluoxetine in adult rats with stress-induced gastric ulcer.
Topics: Animals; Catalase; Cerebral Cortex; Female; Fluoxetine; gamma-Aminobutyric Acid; Gastric Mucosa; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sex Characteristics; Stomach; Stomach Ulcer; Stress, Psychological | 2012 |
Direct alteration of a specific inhibitory circuit of the hippocampus by antidepressants.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Biogenic Monoamines; CA1 Region, Hippocampal; Data Interpretation, Statistical; Electroencephalography; Evoked Potentials; Excitatory Postsynaptic Potentials; Female; Fluoxetine; gamma-Aminobutyric Acid; Hippocampus; Imipramine; Inhibition, Psychological; Interneurons; Male; Nerve Net; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission | 2012 |
Chronic fluoxetine treatment reduces parvalbumin expression and perineuronal nets in gamma-aminobutyric acidergic interneurons of the frontal cortex in adult mice.
Topics: Aging; Animals; Apoptosis; CA3 Region, Hippocampal; Calbindin 2; Cell Count; Fluoxetine; Frontal Lobe; GABAergic Neurons; gamma-Aminobutyric Acid; Interneurons; Male; Mice; Mice, Inbred C57BL; Models, Biological; Parvalbumins; Somatostatin; Thalamus | 2013 |
Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Biophysics; Disease Models, Animal; Down Syndrome; Electric Stimulation; Fluoxetine; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuronal Plasticity; Recognition, Psychology; Space Perception; Synaptosomes | 2014 |
Shu‑Yu capsule, a Traditional Chinese Medicine formulation, attenuates premenstrual syndrome depression induced by chronic stress constraint.
Topics: Animals; Body Mass Index; Depression; Drugs, Chinese Herbal; Female; Fluoxetine; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Medicine, Chinese Traditional; Oleanolic Acid; Premenstrual Syndrome; Rats; Rats, Wistar; Saponins | 2014 |
Animal behavior case of the month. Tail chasing in a dog diagnosed as compulsive disorder.
Topics: Amines; Animals; Anticonvulsants; Behavior, Animal; Bites and Stings; Cyclohexanecarboxylic Acids; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Tail | 2015 |
Gabapentin Treatment in Bruxism Associated With Fluoxetine.
Topics: Adult; Amines; Bruxism; Cyclohexanecarboxylic Acids; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2015 |
Short term, low dose fluoxetine blocks estrous cycle-linked changes in responsiveness to diazepam in female rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain; Diazepam; Estrous Cycle; Estrus; Female; Fluoxetine; gamma-Aminobutyric Acid; Locomotion; Maze Learning; Pregnanolone; Rats; Rats, Wistar; Receptors, GABA-A; Selective Serotonin Reuptake Inhibitors; Serotonin | 2016 |
Fluoxetine disrupts motivation and GABAergic signaling in adolescent female hamsters.
Topics: Anhedonia; Animals; Anxiety; Brain-Derived Neurotrophic Factor; Conflict, Psychological; Cricetinae; Exploratory Behavior; Feeding Behavior; Female; Fluoxetine; gamma-Aminobutyric Acid; Inhibitory Postsynaptic Potentials; Motivation; Neuronal Plasticity; Nucleus Accumbens; Receptors, GABA-A; Reward; RNA, Messenger; Sexual Maturation; Tissue Culture Techniques | 2016 |
Recovery effect of pre-germinated brown rice on the alteration of sperm quality, testicular structure and androgen receptor expression in rat model of depression.
Topics: Animals; Antidepressive Agents; Depressive Disorder; Disease Models, Animal; Fluoxetine; gamma-Aminobutyric Acid; Male; Oryza; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Sperm Motility; Spermatozoa; Swimming; Testis | 2017 |
Anxiety and depression with neurogenesis defects in exchange protein directly activated by cAMP 2-deficient mice are ameliorated by a selective serotonin reuptake inhibitor, Prozac.
Topics: Affect; Aged; Aged, 80 and over; Alzheimer Disease; Animals; Anxiety; Asian People; Behavior, Animal; Cyclic AMP; Depression; Female; Fluoxetine; gamma-Aminobutyric Acid; Guanine Nucleotide Exchange Factors; Hippocampus; Humans; Male; Mice, Knockout; Neurogenesis; Restraint, Physical; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2016 |
Fluoxetine Suppresses Glutamate- and GABA-Mediated Neurotransmission by Altering SNARE Complex.
Topics: Animals; Calcium Channels; Exocytosis; Female; Fluoxetine; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Models, Neurological; Presynaptic Terminals; Protein Kinase C; Rats, Wistar; SNARE Proteins; Synaptic Transmission | 2019 |
Depressive-like behaviors in mice with Imiquimod-induced psoriasis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Brain; Cytokines; Depression; Disease Models, Animal; Epinephrine; Exploratory Behavior; Fluoxetine; Food Preferences; gamma-Aminobutyric Acid; Imiquimod; Male; Mice, Inbred BALB C; Neurotransmitter Agents; Norepinephrine; Open Field Test; Psoriasis; Serotonin; Skin | 2020 |
Saffron essential oil ameliorates CUMS-induced depression-like behavior in mice via the MAPK-CREB1-BDNF signaling pathway.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Crocus; Depression; Disease Models, Animal; Dopamine; Eosine Yellowish-(YS); Fluoxetine; gamma-Aminobutyric Acid; Hematoxylin; Hippocampus; MAP Kinase Signaling System; Mice; Neuroprotective Agents; Oils, Volatile; Serotonin; Signal Transduction; Stress, Physiological; Stress, Psychological; Sucrose | 2023 |
Mechanism of lily bulb and Rehmannia decoction in the treatment of lipopolysaccharide-induced depression-like rats based on metabolomics study and network pharmacology.
Topics: Animals; Antidepressive Agents; Cytokines; Depression; Drugs, Chinese Herbal; Endocannabinoids; Fluoxetine; gamma-Aminobutyric Acid; Glycosylphosphatidylinositols; Hormones; Interleukin-6; Lilium; Lipopolysaccharides; Metabolomics; Network Pharmacology; Plant Extracts; Rats; Rehmannia; Serotonin; Tumor Necrosis Factor-alpha | 2022 |